Boehringer Ingelheim

Partner name
Boehringer Ingelheim

About our partnership
Boehringer Ingelheim has been actively supporting the stroke community since 2003 and Stroke Foundation since 2010.

Boehringer Ingelheim is actively engaged in our partnership to support improved health outcomes for stroke survivors.

As Stroke Foundation Major Partner, Boehringer Ingelheim has provided support for a number of projects including the No Postcode Untouched report and InformMe, portal dedicated to supporting health professionals.

About our partner
At Boehringer Ingelheim our purpose is simply to ‘Make More Health’ - for patients, our people and our community. For 130 years we have remained a family-owned, independent company and today operate globally employing more than 50, 000 people.

We practice excellence, innovation and value in the discovery of new medicines and services and are committed to operating as an ethical and sustainable company. We constantly seek new and better ways to treat diseases in people and animals.

In Australia and New Zealand, Boehringer Ingelheim operates in the areas of Prescription Medicine, Animal Health and the production of duboisia, a native Australian plant.

Find out more about Boehringer Ingelheim